Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer

Share this content:
Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer

Sponsors and Collaborators
Radiation Therapy Oncology Group
National Cancer Institute (NCI)

Principal Investigator
M. Dror Michaelson, MD, PhD, Massachusetts General Hospital

ClinicalTrials.gov Identifier
NCT01546987

You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters